HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Turco, S. D. Articles by De Caterina, R. PubMed PubMed Citation Articles by Turco, S. D. Articles by De Caterina, R. Related Collections Related Article

Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction

¹ CNR Institute of Clinical Physiology, Pisa;
² Department of Pathology, University of Siena, Italy;
³ Department of Nephrology, Aalborg Hospital, Århus University, Denmark;
⁴ Department of Preventive Cardiology;
⁵ Institute of Cardiology and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy

Correspondence: Raffaele De Caterina, MD, PhD, Chair and Postgraduate School of Cardiology, "G. d'Annunzio" University Chieti, Ospedale Clinicizzato S.S. Annunziata, via dei Vestini, 66013 Chieti, Italy. E-mail:rdecater{at}unich.it

Background: Increased levels of microparticles exposing tissue factor circulate in the blood of patients with coronary heart disease, possibly disseminating their pro-thrombotic and pro-inflammatory potential. Because diets rich in n-3 (polyunsaturated) fatty acids have been associated with reduced incidence of coronary heart disease-related events, we investigated the in vivo effects of treatments with n-3 fatty acids on levels of circulating microparticles and their tissue factor- dependent procoagulant activity in patients with a previous myocardial infarction.

Design and Methods: Forty-six post-myocardial infarction patients were assigned to receive either 5.2 g of n-3 fatty acids daily (n=23) or an olive oil placebo (n=23) for 12 weeks. Circulating microparticles were isolated from peripheral blood. The number of microparticles, their cellular source and tissue factor antigen were determined by flow cytometry, and their procoagulant potential assayed by a fibrin generation test.

Results: The total number of microparticles, endothelium-derived microparticles and microparticle tissue factor antigen were not significantly different between the two groups. However, the number of platelet-derived microparticles [from a median of 431 (126–1796, range) x10⁶/L to a median of 226 (87–677, range)] x10⁶/L and monocyte-derived microparticles [from a median of 388 (9–1681, range) x10⁶/L to a median of 265 (7–984, range) x10⁶/L] in plasma were significantly (p<0.05) decreased by n-3 fatty acids, while they were unchanged in the placebo group. Total microparticle tissue factor-procoagulant activity was also reduced in the n-3 fatty acid group compared to that in the placebo group.

Conclusions: Treatment with n-3 fatty acids after myocardial infarction exerts favorable effects on levels of platelet- and monocyte-derived microparticles, thus possibly explaining some of the anti-inflammatory and anti-thrombotic properties of these natural compounds.

Key words: tissue factor, microparticles, platelets, endothelium, thrombosis, coronary heart disease.

Related Article

n-3 fatty acids and cardiovascular disease

Heidi Grundt, Dennis W.T. Nilsen
Haematologica 2008 93: 807-812. [Full Text] [PDF]

This article has been cited by other articles:

				H. Grundt and D. W.T. Nilsen n-3 fatty acids and cardiovascular disease Haematologica, June 1, 2008; 93(6): 807 - 812. [Full Text] [PDF]